KR102608876B1 - 글리칸 분석을 위한 효소 - Google Patents

글리칸 분석을 위한 효소 Download PDF

Info

Publication number
KR102608876B1
KR102608876B1 KR1020197036845A KR20197036845A KR102608876B1 KR 102608876 B1 KR102608876 B1 KR 102608876B1 KR 1020197036845 A KR1020197036845 A KR 1020197036845A KR 20197036845 A KR20197036845 A KR 20197036845A KR 102608876 B1 KR102608876 B1 KR 102608876B1
Authority
KR
South Korea
Prior art keywords
gly
lys
ala
thr
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197036845A
Other languages
English (en)
Korean (ko)
Other versions
KR20200011955A (ko
Inventor
프레드릭 레오
롤프 루드
스티븐 비요크
마린 메야르
프레드릭 올손
Original Assignee
게노비스 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1708471.6A external-priority patent/GB201708471D0/en
Priority claimed from GBGB1708476.5A external-priority patent/GB201708476D0/en
Priority claimed from GBGB1806655.5A external-priority patent/GB201806655D0/en
Application filed by 게노비스 에이비 filed Critical 게노비스 에이비
Publication of KR20200011955A publication Critical patent/KR20200011955A/ko
Application granted granted Critical
Publication of KR102608876B1 publication Critical patent/KR102608876B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24057O-Sialoglycoprotein endopeptidase (3.4.24.57), i.e. glycoprotease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/952Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
KR1020197036845A 2017-05-26 2018-05-25 글리칸 분석을 위한 효소 Active KR102608876B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1708471.6A GB201708471D0 (en) 2017-05-26 2017-05-26 Polypeptide
GBGB1708476.5A GB201708476D0 (en) 2017-05-26 2017-05-26 Tools for glycan analysis
GB1708471.6 2017-05-26
GB1708476.5 2017-05-26
GBGB1806655.5A GB201806655D0 (en) 2018-04-24 2018-04-24 Polypeptide
GB1806655.5 2018-04-24
PCT/EP2018/063833 WO2018215657A1 (en) 2017-05-26 2018-05-25 Enzymes for glycan analysis

Publications (2)

Publication Number Publication Date
KR20200011955A KR20200011955A (ko) 2020-02-04
KR102608876B1 true KR102608876B1 (ko) 2023-11-30

Family

ID=62492612

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020197036845A Active KR102608876B1 (ko) 2017-05-26 2018-05-25 글리칸 분석을 위한 효소
KR1020197036837A Active KR102609790B1 (ko) 2017-05-26 2018-05-25 O-당단백질에 대한 프로테아제 및 결합 폴리펩티드

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197036837A Active KR102609790B1 (ko) 2017-05-26 2018-05-25 O-당단백질에 대한 프로테아제 및 결합 폴리펩티드

Country Status (14)

Country Link
US (3) US12448614B2 (https=)
EP (2) EP3630967B8 (https=)
JP (3) JP7195008B2 (https=)
KR (2) KR102608876B1 (https=)
CN (2) CN111183220B (https=)
AU (2) AU2018272984B2 (https=)
CA (2) CA3063815A1 (https=)
DK (2) DK3630967T3 (https=)
ES (2) ES2986910T3 (https=)
FI (2) FI3630968T3 (https=)
IL (2) IL270949B2 (https=)
PL (2) PL3630968T3 (https=)
PT (2) PT3630968T (https=)
WO (2) WO2018215656A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111183220B (zh) 2017-05-26 2024-03-22 杰诺维斯公司 用于聚糖分析的工具
CN114258431A (zh) * 2019-07-03 2022-03-29 帕利昂制药有限公司 重组人唾液酸酶、唾液酸酶融合蛋白及其使用方法
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
US20250051821A1 (en) * 2021-12-15 2025-02-13 Danisco Us Inc. Compositions and methods involving proteases specific for mannose-modified proteins
EP4627340A1 (en) * 2022-11-28 2025-10-08 Amgen Inc. Method of processing etanercept
US20260092921A1 (en) 2024-09-27 2026-04-02 Roche Diagnostics Gmbh Mutated neuroaminidase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112751A1 (en) 2002-11-22 2005-05-26 Fang Fang Novel class of therapeutic protein based molecules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720165B2 (en) 2001-06-14 2004-04-13 Zyomix, Inc. Methods for making antibody fragments and compositions resulting therefrom
GB0624874D0 (en) 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
WO2009129086A2 (en) 2008-04-18 2009-10-22 New England Biolabs, Inc. Endoglycosidases that cleave o-linked glycans
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
WO2010111674A2 (en) * 2009-03-27 2010-09-30 Life Technologies Corporation Methods and apparatus for single molecule sequencing using energy transfer detection
GB201115841D0 (en) 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
WO2016003795A1 (en) 2014-07-02 2016-01-07 New England Biolabs, Inc. Universal n-glycan binding reagent
WO2017052433A1 (en) 2015-09-24 2017-03-30 Saab Ab A modular fluid actuator system
AU2017214441B2 (en) 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases
CN111183220B (zh) * 2017-05-26 2024-03-22 杰诺维斯公司 用于聚糖分析的工具

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112751A1 (en) 2002-11-22 2005-05-26 Fang Fang Novel class of therapeutic protein based molecules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Carbohydrate Research, vol. 415, p60-65(2015-08-14)*
JOURNAL OF VISUALIZED EXPERIMENTS, no. 58, p1-5(2011-12-26)*

Also Published As

Publication number Publication date
CN111183221B (zh) 2024-04-09
US12448614B2 (en) 2025-10-21
EP3630967A1 (en) 2020-04-08
US20230212543A1 (en) 2023-07-06
DK3630967T3 (da) 2024-08-19
JP2023103233A (ja) 2023-07-26
AU2018272984B2 (en) 2024-05-23
EP3630968B1 (en) 2024-05-29
FI3630967T3 (fi) 2024-08-12
KR102609790B1 (ko) 2023-12-04
US11584922B2 (en) 2023-02-21
FI3630968T3 (fi) 2024-07-24
PT3630968T (pt) 2024-07-30
WO2018215656A1 (en) 2018-11-29
AU2018272984A1 (en) 2019-12-05
CN111183220A (zh) 2020-05-19
AU2018272400A1 (en) 2019-12-05
PL3630967T3 (pl) 2024-11-18
JP7195008B2 (ja) 2022-12-23
US20200172889A1 (en) 2020-06-04
EP3630968A1 (en) 2020-04-08
WO2018215656A9 (en) 2019-03-14
WO2018215657A1 (en) 2018-11-29
PT3630967T (pt) 2024-08-21
ES2986910T3 (es) 2024-11-13
WO2018215657A9 (en) 2019-03-14
AU2018272400B2 (en) 2024-06-13
CA3063828A1 (en) 2018-11-29
ES2986557T3 (es) 2024-11-11
IL270950B2 (en) 2025-06-01
EP3630967B1 (en) 2024-06-12
CN111183221A (zh) 2020-05-19
KR20200010322A (ko) 2020-01-30
IL270949B2 (en) 2025-06-01
IL270949A (en) 2020-01-30
CN111183220B (zh) 2024-03-22
CA3063815A1 (en) 2018-11-29
IL270950A (en) 2020-01-30
JP7557896B2 (ja) 2024-09-30
IL270950B1 (en) 2025-02-01
US12529044B2 (en) 2026-01-20
KR20200011955A (ko) 2020-02-04
IL270949B1 (en) 2025-02-01
PL3630968T3 (pl) 2024-10-07
DK3630968T3 (da) 2024-07-29
JP2020522242A (ja) 2020-07-30
EP3630967B8 (en) 2024-07-17
EP3630968B8 (en) 2024-07-03
US20200087643A1 (en) 2020-03-19
JP2020521460A (ja) 2020-07-27

Similar Documents

Publication Publication Date Title
KR102608876B1 (ko) 글리칸 분석을 위한 효소
KR102001427B1 (ko) 스트렙토코쿠스 피오게네스 유래의 엔도글리코시다아제 및 그의 이용방법
CA2893645C (en) Method for recombinant production of horseshoe crab factor c protein in protozoa
Dahl et al. Carica papaya glutamine cyclotransferase belongs to a novel plant enzyme subfamily: cloning and characterization of the recombinant enzyme
US9545431B1 (en) Isolated recombinant cDNA
RU2807615C2 (ru) Способ получения биологически активных рекомбинантных протеинов

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20191212

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210518

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230223

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230922

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20231128

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20231128

End annual number: 3

Start annual number: 1

PG1601 Publication of registration